Maccon Keane

9.7k total citations
72 papers, 3.4k citations indexed

About

Maccon Keane is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maccon Keane has authored 72 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 33 papers in Cancer Research and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maccon Keane's work include Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (10 papers) and Cell death mechanisms and regulation (9 papers). Maccon Keane is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (10 papers) and Cell death mechanisms and regulation (9 papers). Maccon Keane collaborates with scholars based in Ireland, United States and United Kingdom. Maccon Keane's co-authors include Seth A. Ettenberg, Marion M. Nau, Stan Lipkowitz, E K Russell, Stanley Lipkowitz, Mauricio Cuello, Devalingam Mahalingam, Éva Szegezdi, Afshin Samali and Steven de Jong and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Maccon Keane

71 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maccon Keane Ireland	27	1.9k	1.5k	926	630	520	72	3.4k
Urban Emmenegger Canada	32	1.3k 0.7×	1.5k 1.0×	930 1.0×	463 0.7×	352 0.7×	150	3.4k
Yongmei Yin China	32	1.7k 0.9×	1.3k 0.9×	1.2k 1.3×	470 0.7×	271 0.5×	200	3.5k
Li‐E Wang United States	37	2.2k 1.1×	1.1k 0.7×	910 1.0×	219 0.3×	461 0.9×	88	3.4k
Shunchang Jiao China	30	1.1k 0.6×	1.9k 1.2×	655 0.7×	618 1.0×	389 0.7×	144	3.4k
Hiroko Bando Japan	27	1.2k 0.6×	1.5k 1.0×	844 0.9×	719 1.1×	170 0.3×	121	3.1k
Patrizia Vici Italy	34	867 0.5×	1.9k 1.3×	782 0.8×	402 0.6×	286 0.6×	206	3.6k
Frank Stenner Switzerland	28	1.4k 0.7×	1.1k 0.8×	313 0.3×	1.2k 1.9×	617 1.2×	108	3.4k
D. Vucicevic United States	9	1.2k 0.6×	1.8k 1.2×	981 1.1×	244 0.4×	544 1.0×	30	3.6k
Nina J. Karlin United States	15	1.4k 0.8×	2.2k 1.4×	1.1k 1.2×	252 0.4×	555 1.1×	47	4.1k
Yang Lü United States	35	1.9k 1.0×	1.9k 1.2×	906 1.0×	312 0.5×	723 1.4×	171	4.5k

Countries citing papers authored by Maccon Keane

Since Specialization

Citations

This map shows the geographic impact of Maccon Keane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maccon Keane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maccon Keane more than expected).

Fields of papers citing papers by Maccon Keane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maccon Keane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maccon Keane. The network helps show where Maccon Keane may publish in the future.

Co-authorship network of co-authors of Maccon Keane

This figure shows the co-authorship network connecting the top 25 collaborators of Maccon Keane. A scholar is included among the top collaborators of Maccon Keane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maccon Keane. Maccon Keane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davey, Matthew G., Ronan Waldron, Emma Holian, et al.. (2022). Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer. Annals of Surgery. 276(5). 905–912. 22 indexed citations

Evoy, Denis, James Geraghty, R S Prichard, et al.. (2021). Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland. Breast Cancer Research and Treatment. 188(3). 789–798. 6 indexed citations

Davey, Matthew G., Elizabeth A. Maher, Peter McAnena, et al.. (2021). Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study. The Breast. 59. 67–75. 21 indexed citations

Evoy, Denis, James Geraghty, Ruth Prichard, et al.. (2020). Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.. Journal of Clinical Oncology. 38(15_suppl). 540–540. 1 indexed citations

Lowery, Aoïfe, Catherine Curran, Ray McLaughlin, et al.. (2019). A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes. Clinical Breast Cancer. 19(5). 377–382. 22 indexed citations

McVeigh, Terri, et al.. (2018). Neoadjuvant chemoradiation and breast reconstruction: the potential for improved outcomes in the treatment of breast cancer. Irish Journal of Medical Science (1971 -). 188(1). 75–83. 17 indexed citations

Sonnenblick, Amir, Dominique Agbor‐Tarh, Ian Bradbury, et al.. (2017). Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial. Journal of Clinical Oncology. 35(13). 1421–1429. 106 indexed citations

McVeigh, Terri, Nicola Miller, Margaret Sheehan, et al.. (2014). The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre. European Journal of Cancer. 50(16). 2763–2770. 59 indexed citations

Coleman, Robert E., David Cameron, David Dodwell, et al.. (2014). Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. The Lancet Oncology. 15(9). 997–1006. 202 indexed citations

10.

Smyth, C., et al.. (2013). Fertility preservation in young females with non-gynaecologic malignancy: an emerging speciality. Irish Journal of Medical Science (1971 -). 183(1). 33–38. 2 indexed citations

11.

McVeigh, Terri, Dhafir Al-Azawi, Carmel Malone, et al.. (2013). Assessing the Impact of Neoadjuvant Chemotherapy on the Management of the Breast and Axilla in Breast Cancer. Clinical Breast Cancer. 14(1). 20–25. 15 indexed citations

12.

Coleman, Robert E., Matthew Winter, David Cameron, et al.. (2010). The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer. 102(7). 1099–1105. 168 indexed citations

13.

Mahalingam, Devalingam, Alessandro Natoni, Maccon Keane, Afshin Samali, & Éva Szegezdi. (2010). Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. British Journal of Cancer. 102(4). 754–764. 37 indexed citations

14.

Mahalingam, Devalingam, Éva Szegezdi, Maccon Keane, Steven de Jong, & Afshin Samali. (2008). TRAIL receptor signalling and modulation: Are we on the right TRAIL?. Cancer Treatment Reviews. 35(3). 280–288. 230 indexed citations

15.

Szegezdi, Éva, Devalingam Mahalingam, Almer M. van der Sloot, et al.. (2007). Decoy-insensitive TRAIL variants kill tumour cells more efficiently without damaging non-transformed cells. Cancer Research. 67. 5170–5170. 1 indexed citations

16.

Cuello, Mauricio, Seth A. Ettenberg, Amy S. Clark, et al.. (2001). Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.. PubMed. 61(12). 4892–900. 301 indexed citations

17.

Klein, Pamela, Liam Grogan, Maccon Keane, et al.. (2001). Biomarker Assays in Nipple Aspirate Fluid. The Breast Journal. 7(6). 378–387. 32 indexed citations

18.

Keane, Maccon, Seth A. Ettenberg, Marion M. Nau, E K Russell, & Stanley Lipkowitz. (1999). Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.. PubMed. 59(3). 734–41. 483 indexed citations

19.

Chen, Weidong, Joseph Geradts, Maccon Keane, et al.. (1999). The 100-kDa Proteolytic Fragment of RB Is Retained Predominantly within the Nuclear Compartment of Apoptotic Cells. PubMed. 1(3). 216–220. 2 indexed citations

20.

Keane, Maccon, et al.. (1996). The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.. PubMed. 56(18). 4236–43. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact